Status of minimal residual disease determines outcome of autologous hematopoietic SCT in adult ALL-Reference-Cited by-同舟云学术

Status of minimal residual disease determines outcome of autologous hematopoietic SCT in adult ALL

Published:2009-10-26 Issue:6 Volume:45 Page:1095-1101
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Giebel S, ,Stella-Holowiecka B,Krawczyk-Kulis M,Gökbuget N,Hoelzer D,Doubek M,Mayer J,Piatkowska-Jakubas B,Skotnicki A B,Dombret H,Ribera J M,Piccaluga P P,Czerw T,Kyrcz-Krzemien S,Holowiecki J

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/bmt2009308.pdf

Reference28 articles.

1. Rowe JM, Goldstone AH . How I treat acute lymphocytic leukemia in adults. Blood 2007; 110: 2268–2275.

2. Hoelzer D, Thiel E, Löffler H, Büchner T, Ganser A, Heil G et al. Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults. Blood 1988; 71: 123–131.

3. Hahn T, Wall D, Camitta B, Davies S, Dillon H, Gaynon P et al. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute lymphoblastic leukemia in adults: an evidence-based review. Biol Blood Marrow Transplant 2006; 12: 1–30.

4. Willemze R, Labar B . Post-remission treatment for adult patients with acute lymphoblastic leukemia in first remission: is there a role for autologous stem cell transplantation? Semin Hematol 2007; 44: 267–273.

5. Thomas X, Boiron JM, Huguet F, Dombret H, Bradstock K, Vey N et al. Outcome of treatment in adults with acute lymphoblastic leukemia: analysis of the LALA-94 trial. J Clin Oncol 2004; 22: 4075–4086.

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of ALL in adults: 2024 ELN recommendations from a European expert panel;Blood;2024-05-09

2. Safety and efficacy of CD22 and CD19 CAR-T bridging auto-HSCT as consolidation therapy for AYA and adult B-ALL;Blood Cancer Journal;2023-05-03

3. Autologous versus allogeneic hematopoietic cell transplantation for older patients with acute lymphoblastic leukemia. An analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation;Bone Marrow Transplantation;2023-01-07

4. Flow Cytometric Techniques in the Diagnosis and Monitoring of Acute Leukaemias;Pathogenesis and Treatment of Leukemia;2023

5. Propensity score matching/reweighting analysis comparing autologous and allogeneic stem cell transplantation for B-lineage acute lymphoblastic leukemia;International Journal of Hematology;2022-05-10